Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Organon & Co. Earnings Release 2026

Apr 30, 2026

31461_rns_2026-04-30_61318ff4-7768-49f3-b67f-a1bea9cff4f5.zip

Earnings Release

Open in viewer

Opens in your device viewer

Field: Rule-Page

Field: /Rule-Page

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 30, 2026

Organon & Co.

(Exact name of registrant as specified in its charter)

Delaware 001-40235 46-4838035
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer Identification No.)
incorporation)
30
Hudson Street , Floor
33 , Jersey City , NJ 07302
(Address and principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: ( 551 ) 430-6900

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

| ¨ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| --- | --- |
| x | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Act:

| Title of
each class | Trading
Symbol(s) | Name of
each exchange on which registered |
| --- | --- | --- |
| Common
Stock, par value $0.01 per share | OGN | NYSE |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Item 2.02 Results of Operations and Financial Condition.

On April 30, 2026, Organon & Co. (the “ Company ”) issued a press release (the “ Earnings Release ”) regarding its results for the quarter ended March 31, 2026. A copy of the Earnings Release is included as Exhibit 99.1 to this report.

The information contained in this Item 2.02, including Exhibit 99.1 attached hereto, is considered to be “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to liability under that Section. The information in this Current Report shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended (the “ Securities Act ”) or the Exchange Act, except as shall be expressly set forth by specific reference in such filing or document. The release contains forward-looking statements regarding the Company and includes a cautionary statement identifying important factors that could cause actual results to differ materially from those anticipated.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. Description
99.1 Press Release, dated April 30, 2026, relating to results of operations and financial condition.
104 The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

/s/ Matthew Walsh
Name: Matthew Walsh
Title: Chief Financial Officer

Dated: April 30, 2026

Field: Page; Sequence: 3; Options: Last

Field: /Page

Field: Set; Name: xdx; ID: xdx_08B_extensions eJxFjd0KgkAQhZ/Adxj2OkyXJPCupCSyCInodssxlnRHZre/R+ot25RoGBiGc75zhBiJnJa6QYbjvCxgj23XKIdQYo2M5ozeka3WKfhb4kVbx8q4/v2BGXkGPZOEUp680Fvv2mKVQpSM4+lYTiCWaSJhthHBV8/I1LpC47RqQJkKdkwda3SKX0PCXj3JUPvqqw7IVpNJIQ6jQX6DjGIJW7qrB/HVQlFkIhj1E4ic6dZ51+Lp0HxJWDTY+jo70P8NPgA1SoE=